1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07987890 2023-04-01 2024-03-31 07987890 2024-03-31 07987890 2023-03-31 07987890 2022-04-01 2023-03-31 07987890 2023-03-31 07987890 2022-03-31 07987890 bus:Director1 2023-04-01 2024-03-31 07987890 core:WithinOneYear 2024-03-31 07987890 core:WithinOneYear 2023-03-31 07987890 core:ShareCapital 2024-03-31 07987890 core:ShareCapital 2023-03-31 07987890 core:RetainedEarningsAccumulatedLosses 2024-03-31 07987890 core:RetainedEarningsAccumulatedLosses 2023-03-31 07987890 bus:SmallEntities 2023-04-01 2024-03-31 07987890 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07987890 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07987890 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07987890 bus:FullAccounts 2023-04-01 2024-03-31 07987890 core:Associate1 2023-04-01 2024-03-31 07987890 core:Associate1 2024-03-31 07987890 core:Associate1 2023-03-31
COMPANY REGISTRATION NUMBER: 07987890
Go Medical UK Limited
Filleted Unaudited Financial Statements
31 March 2024
Go Medical UK Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
Current assets
Debtors
5
5,541
5,541
Cash at bank and in hand
3,253
2,977
-------
-------
8,794
8,518
Creditors: amounts falling due within one year
6
36,199
35,226
--------
--------
Net current liabilities
27,405
26,708
--------
--------
Total assets less current liabilities
( 27,405)
( 26,708)
--------
--------
Net liabilities
( 27,405)
( 26,708)
--------
--------
Capital and reserves
Called up share capital
10
10
Profit and loss account
( 27,415)
( 26,718)
--------
--------
Members' deficit
( 27,405)
( 26,708)
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: - The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476; - The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 25 March 2025 , and are signed on behalf of the board by:
Patsy Graieg
Director
Company registration number: 07987890
Go Medical UK Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. Statutory information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Deansfield House, 98 Lancaster Road, Newcastle under Lyme, Staffordshire, ST5 1DS.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Companies Act 2006.
3. Accounting policies
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Going concern
The financial statements have been prepared on the going concern basis, as disclosed in note 8.
(c) Taxation
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(d) Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Debtors
2024
2023
£
£
Other debtors
5,541
5,541
-------
-------
6. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
13
Amounts owed to group undertakings and undertakings in which the company has a participating interest
32,974
30,814
Other creditors
3,212
4,412
--------
--------
36,199
35,226
--------
--------
7. Related party transactions
Patsy Graieg is a related party by virtue of her directorship of and shareholding in the company. Go Medical UK Limited is a 90% subsidiary of Go Medical Industries Pty Ltd, of which Patsy Graieg is also a director. The ultimate parent undertaking is Palmaya Pty Ltd, ACN: 009 024 346, incorporated in Australia and its registered office is 200 Churchill Avenue, Subiaco, WA 6008. Go Medical Industries Pty Ltd paid expenses on behalf of the company is the sum of £2,160 (2023: £2,383). At the year end, the company owed Go Medical Industries Pty Ltd the sum of £ 32,974 (2023: £ 30,814 ). This loan was interest free and repayable on demand.
8. Going concern
The director has confirmed that Go Medical Industries Pty Ltd will continue to provide financial support by way of the non-recalling of its loan to the company in order to enable Go Medical UK Limited to finance its trading and other obligations for the foreseeable future.
Based on the above, the financial statements have been prepared on the going concern basis.